Concepedia

Yoshie Umemura

YU

15

Publications

1.6K

Citations

15

H-Index

2011

Active since

Affiliations

University of Michigan(Current)

Memorial Sloan Kettering Cancer Center

University of California, San Francisco

University of California, Los Angeles

Dana-Farber Cancer Institute

Yoshie Umemura is an author at University of Michigan specializing in medicine, high-grade gliomas, and glioma.

ORCID

Top concepts

Publications per year

2011–2024

15

Publications

15

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 606 citations · Full text

Purine metabolism regulates DNA repair and therapy resistance in glioblastoma

Weihua Zhou, Yangyang Yao, Andrew J. Scott et al. · Nature Communications · 2020 · 246 citations · Full text

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall et al. · Journal of Neuro-Oncology · 2019 · 187 citations

, , +8

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 130 citations · Full text

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia et al. · Journal of Clinical Oncology · 2024 · 68 citations · Full text

Rows per page

1–5 of 15